BioStock Life Science Summit | May 30-31 | Digitalt event
During the packed two-day event, several compelling life science companies showcased their projects and innovations to investors and potential partners. Additionally, industry experts and investors offered their valuable advice and experiences during the expert insights sessions of the event.
BioStock Life Science Spring Summit is all about connecting innovation and capital. The event is one of the Nordic region’s most important platforms for listed as well as private innovation companies from a wide range of therapeutic areas to present their projects to both Swedish and international investors, industry colleagues and potential partners.
This digital event showcases the great breadth and level of innovation the Nordic life science sector has to offer. The two-day programme can be easily accessed online and conveniently followed from any computer or mobile device.
Watch the programme and the participating companies below.
EVENT PARTNER
Expert Insights: The Big Pharma perspective on M&A and post-deal integration
Anna Gran, Associate Director Corporate Integration at Novo Nordisk, on how smaller companies should prepare for an acquisition – and for life after the deal is signed.
Thuesday May 30 at 11:00
Expert Insights: Fundraising strategies in a bear market
Jonas Ribbelöv, Managing Partner at Vator Securities, talks strategies for raising cash in a challenging market climate.
Wednesday May 31 at 11:20
WATCH ALL PRESENTATIONS
Tuesday May 30
10.00 Carbiotix
10.20 Prolight Diagnostics
10.40 Lipum
11.00 Novo Nordisk
11.20 Cereno Scientific
11.40 Circio
12.00 Annexin Pharmaceuticals
12.20 Ziccum
12.40 Colzyx
13.00 SynAct Pharma
13.20 Pharmacolog
13.40 Arcede Pharma
Wednesday May 31
10.00 BioInvent
10.20 Dicot
10.40 WntResearch
11.00 Bioservo Technologies
11.20 Vator Securities
11.30 Elicera Therapeutics
11.50 AcuCort
12.10 Initiator Pharma
12.30 BioArctic
12.50 Aptahem
13.10 AdjuTec Pharma
13.30 Suturion
13.33 Stardots
13.36 Omnio
13.39 Uptake Bio
COMPANIES
CEO Jonas Jönmark
Focus area Allergic reactions
Marketplace Spotlight Stock Market
Website www.acucort.se/sv
CEO Anders Haegerstrand
Focus area Injuries and inflammation in the blood vessels
Marketplace First North
Website www.annexinpharma.com
CEO Mikael Lindstam
Focus area RNA-based therapeutics
Marketplace Spotlight Stock Market
Website www.aptahem.com
CEO Mia Lundblad
Focus area Pulmonary diseases
Marketplace Spotlight Stock Market
Website www.arcedepharma.com
VP Comm & IR Oskar Bosson
Focus area Neurodegenerative disorders
Marketplace Nasdaq Stockholm
Website www.bioarctic.se
CEO Martin Welschof
Focus area Immuno-oncology
Marketplace Nasdaq Stockholm
Website www.bioinvent.com
CEO Petter Bäckgren
Focus area Powered muscle strengthening devices
Marketplace First North
Website www.bioservo.com
CEO Kristofer Cook
Focus area Prebiotic products
Marketplace Spotlight Stock Market
Website www.carbiotix.com
CEO Sten R. Sörensen
Focus area Cardiovascular diseases
Marketplace Spotlight Stock Market
Website www.cerenoscientific.se
CEO Karin Bryder
Focus area Wound care and antimicrobial products
Marketplace Unlisted
Website www.colzyx.com
CEO Elin Trampe
Focus area Sexual dysfunctions
Marketplace Spotlight Stock Market
Website www.dicot.se
CEO Claus Elsborg Olesen
Focus area Neurological disorders
Marketplace First North
Website www.initiatorpharma.com
CEO Lars Gusch
Focus area Medication safety and drug diversion prevention
Marketplace First North
Website www.pharmacolog.com
CEO Ulf Bladin
Focus area Diagnostic methods
Marketplace Nordic SME Sweden
Website www.prolightdiagnostics.se
CEO Daniel Petrini
Focus area Software-as-a-medical-device
Marketplace Unlisted
Website www.stardots.se
CEO Torbjørn Bjerke
Focus area Inflammatory diseases
Marketplace Nasdaq Stockholm
Website www.synactpharma.com
CEO Pernilla Sandwall
Focus area Oncology
Marketplace Spotlight Stock Market
Website www.wntresearch.com
